CDK1 is overexpressed in breast cancer and functions as a key regulatory factor during the G2/M phase of the cell cycle, thereby promoting tumorigenesis and cancer progression.[33, 34] Bioinformatics analysis showed that CDK1 is significantly overexpressed in breast cancer (Figure S4C, Supporting Information) and correlates with poor survival prognosis in breast cancer patients (Figure S4D, Supporting Information). This evidence concerns the gene CDK1 and breast carcinoma.